American Heart Journal
Volume 143, Issue 5 , Pages 753-759 , May 2002

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes

Received 12 March 2001 ,Accepted 3 October 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Reprint requests: Richard C. Becker, MD, Director, Cardiovascular Thrombosis Research Center, University of Massachusetts Medical School, Worcester, MA 01655.

PII: S0002-8703(02)02296-2

doi: 10.1067/mhj.2002.120774

American Heart Journal
Volume 143, Issue 5 , Pages 753-759 , May 2002

Article Tools

* Image Usage & Resolution